TIMOLOL MALEATE

TIMOLOL MALEATE was reported 9965 times

TIMOLOL MALEATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VERTEBRAL END PLATE INFLAMMATION 8 0.4000
1 PROCOLLAGEN TYPE I C-TERMINAL PROPEPTIDE INCREASED 7 0.2414
2 SERUM PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE INCREASED 6 0.1935
3 TRABECULECTOMY 10 0.1087
4 DEVELOPMENTAL GLAUCOMA 6 0.0923
5 CORNEAL DEPOSITS 44 0.0591
6 FLAT ANTERIOR CHAMBER OF EYE 9 0.0503
7 INTRAOCULAR PRESSURE FLUCTUATION 9 0.0457
8 ANTERIOR CHAMBER DISORDER 10 0.0435
9 EOSINOPHILIC CELLULITIS 9 0.0423
10 GLAUCOMA SURGERY 9 0.0352
11 CORNEAL GRAFT REJECTION 7 0.0333
12 HYPOTONY OF EYE 14 0.0333
13 INTRAOCULAR PRESSURE TEST ABNORMAL 22 0.0312
14 CHOROIDAL DETACHMENT 17 0.0306
15 ECTROPION 9 0.0267
16 EYE REDNESS 7 0.0250
17 INTRAOCULAR PRESSURE INCREASED 318 0.0249
18 CORNEAL DEGENERATION 6 0.0248
19 REACTION TO PRESERVATIVES 20 0.0246
20 GROWTH OF EYELASHES 19 0.0240
21 EYELID PAIN 47 0.0231
22 HYPHAEMA 12 0.0230
23 INTRAOCULAR PRESSURE DECREASED 12 0.0228
24 PRODUCT DROPPER ISSUE 17 0.0216
25 TOXIC ANTERIOR SEGMENT SYNDROME 23 0.0211
26 IRIS ADHESIONS 10 0.0195
27 MILIA 7 0.0193
28 PERIORBITAL PAIN 16 0.0189
29 CHOROIDAL EFFUSION 15 0.0187
30 CORNEAL DYSTROPHY 6 0.0144
31 CORNEAL EPITHELIUM DEFECT 8 0.0138
32 EYE BURNS 8 0.0136
33 OPEN ANGLE GLAUCOMA 8 0.0130
34 TREATMENT FAILURE 1015 0.0122
35 INTRAOCULAR LENS IMPLANT 6 0.0121
36 CORNEAL SCAR 6 0.0119
37 GLARE 6 0.0117
38 CORNEAL TRANSPLANT 9 0.0115
39 FOREIGN BODY SENSATION IN EYES 73 0.0114
40 INSTILLATION SITE ERYTHEMA 6 0.0114
41 GLAUCOMA 216 0.0112
42 INSTILLATION SITE IRRITATION 13 0.0110
43 SUPERFICIAL INJURY OF EYE 12 0.0110
44 EYELID IRRITATION 27 0.0108
45 CORNEAL OEDEMA 23 0.0103
46 OCULAR HYPERTENSION 19 0.0098
47 CORNEAL DISORDER 21 0.0096
48 SICK SINUS SYNDROME 11 0.0096
49 CONJUNCTIVAL HYPERAEMIA 34 0.0095
50 EYE PAIN 535 0.0095
51 CONJUNCTIVITIS ALLERGIC 14 0.0094
52 EYELID MARGIN CRUSTING 26 0.0090
53 EYELID EXFOLIATION 7 0.0089
54 PRODUCT CONTAINER ISSUE 74 0.0086
55 EYE IRRITATION 492 0.0085
56 ERYTHEMA OF EYELID 46 0.0085
57 VENOUS INSUFFICIENCY 6 0.0083
58 ABNORMAL SENSATION IN EYE 35 0.0081
59 EYELIDS PRURITUS 25 0.0080
60 CHROMATOPSIA 6 0.0079
61 EYELID DISORDER 18 0.0078
62 CONJUNCTIVAL OEDEMA 8 0.0078
63 OCULAR DISCOMFORT 87 0.0077
64 FOREIGN BODY IN EYE 7 0.0073
65 ENDOCRINE OPHTHALMOPATHY 6 0.0069
66 EYE PRURITUS 221 0.0066
67 OCULAR HYPERAEMIA 309 0.0065
68 EYE DISCHARGE 64 0.0062
69 SWELLING OF EYELID 38 0.0060
70 OPTIC NERVE INJURY 7 0.0060
71 ANGLE CLOSURE GLAUCOMA 15 0.0059
72 THROMBOCYTOPENIC PURPURA 8 0.0058
73 VITREOUS HAEMORRHAGE 16 0.0058
74 PRODUCT DEPOSIT 9 0.0058
75 EYE INFLAMMATION 53 0.0055
76 BRADYARRHYTHMIA 9 0.0055
77 ULCERATIVE KERATITIS 15 0.0055
78 PRODUCT DELIVERY MECHANISM ISSUE 29 0.0054
79 LACRIMATION INCREASED 161 0.0053
80 EYE ALLERGY 8 0.0052
81 PHOTOPHOBIA 97 0.0052
82 INCORRECT DOSE ADMINISTERED BY PRODUCT 8 0.0050
83 VITAMIN B12 DECREASED 14 0.0049
84 BLEPHARITIS 19 0.0047
85 CATARACT OPERATION 27 0.0045
86 INSTILLATION SITE PAIN 11 0.0044
87 EYE INFECTION 50 0.0044
88 KERATOPATHY 7 0.0044
89 CORNEAL OPACITY 6 0.0044
90 READING DISORDER 10 0.0044
91 ESSENTIAL HYPERTENSION 8 0.0044
92 LOBAR PNEUMONIA 8 0.0043
93 NODAL RHYTHM 6 0.0041
94 JOINT NOISE 8 0.0041
95 PERIORBITAL SWELLING 22 0.0039
96 ELECTROCARDIOGRAM T WAVE ABNORMAL 6 0.0038
97 RETINAL VEIN OCCLUSION 11 0.0038
98 VISUAL ACUITY REDUCED 127 0.0038
99 IRIDOCYCLITIS 12 0.0038
100 PUPILLARY REFLEX IMPAIRED 7 0.0038
101 PLASMACYTOMA 7 0.0038
102 ASTHENOPIA 20 0.0036
103 EYE INJURY 11 0.0036
104 AORTIC VALVE INCOMPETENCE 15 0.0035
105 PRODUCT CONTAINER SEAL ISSUE 6 0.0034
106 BLINDNESS UNILATERAL 47 0.0033
107 PULSE ABNORMAL 8 0.0033
108 BUNDLE BRANCH BLOCK LEFT 14 0.0033
109 IRITIS 10 0.0033
110 EYE OPERATION 15 0.0033
111 VITREOUS DETACHMENT 7 0.0032
112 VISUAL DISTURBANCE 18 0.0031
113 EYE SWELLING 115 0.0031
114 RETINAL DISORDER 8 0.0031
115 CEREBRAL ATROPHY 12 0.0030
116 DRY EYE 150 0.0030
117 ENDOPHTHALMITIS 18 0.0030
118 ATRIOVENTRICULAR BLOCK COMPLETE 20 0.0030
119 BLINDNESS TRANSIENT 22 0.0030
120 MYOPIA 7 0.0029
121 PRODUCT USE COMPLAINT 45 0.0029
122 NON-CARDIAC CHEST PAIN 9 0.0028
123 RETINAL TEAR 7 0.0028
124 JAUNDICE CHOLESTATIC 10 0.0028
125 RETINAL DETACHMENT 26 0.0028
126 MACULOPATHY 10 0.0028
127 HORDEOLUM 12 0.0028
128 VISUAL FIELD DEFECT 20 0.0028
129 LUMBAR SPINAL STENOSIS 8 0.0027
130 DEAFNESS NEUROSENSORY 9 0.0027
131 CLOSTRIDIUM TEST POSITIVE 6 0.0027
132 AORTIC ARTERIOSCLEROSIS 7 0.0027
133 ATRIOVENTRICULAR BLOCK 21 0.0027
134 SINUS BRADYCARDIA 26 0.0027
135 ACCIDENTAL EXPOSURE 11 0.0026
136 SCIATICA 42 0.0026
137 BLINDNESS 107 0.0026
138 RECALLED PRODUCT ADMINISTERED 25 0.0026
139 BLOOD PHOSPHORUS INCREASED 7 0.0026
140 VISION BLURRED 352 0.0026
141 RESPIRATORY RATE DECREASED 8 0.0025
142 DEAFNESS UNILATERAL 14 0.0025
143 RETINAL HAEMORRHAGE 18 0.0025
144 HAND DEFORMITY 33 0.0025
145 BILE DUCT STONE 8 0.0025
146 EYELID OEDEMA 29 0.0025
147 EYE DISORDER 81 0.0025
148 CATARACT 146 0.0024
149 EYE OEDEMA 6 0.0024
150 PERSECUTORY DELUSION 6 0.0024
151 PHOTOPSIA 15 0.0024
152 ENDODONTIC PROCEDURE 6 0.0024
153 HEPATIC CYST 8 0.0024
154 CONJUNCTIVAL HAEMORRHAGE 9 0.0024
155 MACULAR DEGENERATION 28 0.0023
156 ANAEMIA MACROCYTIC 5 0.0023
157 VITREOUS FLOATERS 23 0.0023
158 PRODUCT DISPENSING ISSUE 10 0.0023
159 SPINAL COLUMN STENOSIS 11 0.0023
160 ACTINIC KERATOSIS 6 0.0023
161 CAROTID ARTERY STENOSIS 8 0.0023
162 RADICULOPATHY 6 0.0023
163 ANGIONEUROTIC OEDEMA 6 0.0022
164 EYE HAEMORRHAGE 30 0.0022
165 VITAMIN B12 DEFICIENCY 9 0.0022
166 BUNDLE BRANCH BLOCK RIGHT 10 0.0022
167 BRADYCARDIA 114 0.0021
168 FAECAL INCONTINENCE 10 0.0021
169 HEART RATE DECREASED 72 0.0020
170 HAEMORRHAGIC ANAEMIA 9 0.0020
171 ELECTROCARDIOGRAM ABNORMAL 16 0.0020
172 EXTRASYSTOLES 14 0.0020
173 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
174 DIVERTICULUM 14 0.0020
175 PRODUCT CONTAMINATION 7 0.0020
176 BODY HEIGHT DECREASED 21 0.0020
177 ARTERIOSCLEROSIS CORONARY ARTERY 13 0.0020
178 NEPHROGENIC ANAEMIA 9 0.0019
179 BENIGN PROSTATIC HYPERPLASIA 10 0.0019
180 MULTIPLE MYELOMA 9 0.0019
181 PRODUCT ADMINISTRATION ERROR 39 0.0019
182 LIQUID PRODUCT PHYSICAL ISSUE 14 0.0019
183 ABSCESS LIMB 8 0.0019
184 TENSION HEADACHE 8 0.0019
185 ATRIOVENTRICULAR BLOCK FIRST DEGREE 8 0.0018
186 HYPERLIPIDAEMIA 22 0.0018
187 IMMOBILE 8 0.0018
188 OESOPHAGEAL DISORDER 7 0.0018
189 MADAROSIS 21 0.0018
190 HIGH DENSITY LIPOPROTEIN DECREASED 6 0.0018
191 PELVIC FRACTURE 14 0.0018
192 SUPRAVENTRICULAR EXTRASYSTOLES 6 0.0018
193 EYELID PTOSIS 18 0.0018
194 UVEITIS 24 0.0018
195 TRICUSPID VALVE INCOMPETENCE 14 0.0018
196 BRONCHOPNEUMONIA 6 0.0018
197 VISUAL IMPAIRMENT 216 0.0017
198 INTERVERTEBRAL DISC DEGENERATION 16 0.0017
199 APLASTIC ANAEMIA 9 0.0017
200 DEFORMITY 16 0.0017
201 CARDIOMEGALY 21 0.0017
202 RENAL FAILURE CHRONIC 13 0.0017
203 MITRAL VALVE INCOMPETENCE 19 0.0017
204 CONJUNCTIVITIS 31 0.0017
205 HYPERKERATOSIS 9 0.0016
206 RETINOPATHY 6 0.0016
207 MACULAR OEDEMA 9 0.0016
208 HYPOTONIA 16 0.0016
209 PERIPHERAL COLDNESS 22 0.0016
210 PHYSICAL DISABILITY 7 0.0016
211 FACE INJURY 6 0.0016
212 PRODUCT PACKAGING ISSUE 15 0.0016
213 INCREASED UPPER AIRWAY SECRETION 8 0.0016
214 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 16 0.0016
215 PERIORBITAL OEDEMA 8 0.0015
216 EAR DISORDER 7 0.0015
217 GLUCOSE TOLERANCE IMPAIRED 9 0.0015
218 SYNOVIAL CYST 7 0.0015
219 CANDIDIASIS 6 0.0015
220 MIOSIS 12 0.0015
221 EMPHYSEMA 15 0.0015
222 TRIGGER FINGER 6 0.0015
223 PHARMACEUTICAL PRODUCT COMPLAINT 38 0.0015
224 EYE MOVEMENT DISORDER 10 0.0015
225 UPPER-AIRWAY COUGH SYNDROME 12 0.0015
226 NASAL DRYNESS 9 0.0014
227 ORTHOSTATIC HYPOTENSION 25 0.0014
228 PROCEDURAL COMPLICATION 11 0.0014
229 INFUSION SITE ERYTHEMA 12 0.0014
230 HAEMATOCRIT DECREASED 28 0.0014
231 MYOCARDIAL ISCHAEMIA 16 0.0014
232 NOCTURIA 17 0.0014
233 ANOREXIA 18 0.0014
234 CORONARY ARTERY STENOSIS 7 0.0014
235 NASAL DISCOMFORT 11 0.0014
236 ANGINA UNSTABLE 9 0.0014
237 ATRIAL FLUTTER 11 0.0014
238 DIVERTICULUM INTESTINAL 6 0.0014
239 TINNITUS 63 0.0014
240 MELANOCYTIC NAEVUS 6 0.0014
241 SPINAL OSTEOARTHRITIS 12 0.0014
242 RHINITIS 11 0.0014
243 EAR DISCOMFORT 14 0.0014
244 PERIPHERAL VASCULAR DISORDER 7 0.0014
245 POST PROCEDURAL COMPLICATION 26 0.0014
246 RHINITIS ALLERGIC 6 0.0013
247 DIPLOPIA 35 0.0013
248 ATELECTASIS 13 0.0013
249 DERMATITIS 28 0.0013
250 PHARYNGOLARYNGEAL PAIN 7 0.0013
251 FOETAL GROWTH RESTRICTION 8 0.0013
252 BLOOD UREA INCREASED 22 0.0013
253 ECCHYMOSIS 9 0.0013
254 GASTROINTESTINAL MOTILITY DISORDER 7 0.0013
255 FOOD POISONING 7 0.0013
256 COMPRESSION FRACTURE 7 0.0013
257 HALLUCINATION, VISUAL 27 0.0013
258 ARTERIOSCLEROSIS 12 0.0013
259 INFUSION SITE SWELLING 8 0.0013
260 RENAL CYST 10 0.0013
261 VENTRICULAR EXTRASYSTOLES 13 0.0013
262 SUBCUTANEOUS ABSCESS 6 0.0013
263 LIMB OPERATION 6 0.0012
264 PRODUCT LEAKAGE 7 0.0012
265 FULL BLOOD COUNT DECREASED 25 0.0012
266 PROSTATIC SPECIFIC ANTIGEN INCREASED 17 0.0012
267 PRODUCT AVAILABILITY ISSUE 28 0.0012
268 OSTEOARTHRITIS 52 0.0012
269 DELUSION 19 0.0012
270 BLOOD SODIUM DECREASED 23 0.0012
271 BLOOD PRESSURE DIASTOLIC DECREASED 9 0.0012
272 HYPERSENSITIVITY 223 0.0012
273 HYPERKALAEMIA 42 0.0012
274 RED BLOOD CELL COUNT DECREASED 34 0.0012
275 WRIST FRACTURE 14 0.0012
276 CEREBRAL ISCHAEMIA 6 0.0012
277 APNOEA 9 0.0012
278 FAILURE TO THRIVE 6 0.0012
279 PHOTOSENSITIVITY REACTION 19 0.0011
280 MASS 16 0.0011
281 HYPERCHOLESTEROLAEMIA 11 0.0011
282 CONCOMITANT DISEASE AGGRAVATED 7 0.0011
283 DUODENAL ULCER 8 0.0011
284 DRY MOUTH 92 0.0011
285 VERTIGO 69 0.0011
286 RENAL FAILURE ACUTE 48 0.0011
287 HEPATOMEGALY 11 0.0011
288 CHEILITIS 6 0.0011
289 OESOPHAGITIS 12 0.0011
290 NONSPECIFIC REACTION 6 0.0011
291 BASAL CELL CARCINOMA 17 0.0011
292 PRODUCT PHYSICAL CONSISTENCY ISSUE 6 0.0011
293 PSYCHIATRIC SYMPTOM 8 0.0011
294 BLOOD CHOLESTEROL ABNORMAL 5 0.0011
295 DRY THROAT 11 0.0011
296 LOWER GASTROINTESTINAL HAEMORRHAGE 8 0.0011
297 EAR PAIN 21 0.0011
298 SUBARACHNOID HAEMORRHAGE 11 0.0011
299 CARPAL TUNNEL SYNDROME 15 0.0011
300 ISCHAEMIC STROKE 19 0.0011
301 CONTRAINDICATED PRODUCT ADMINISTERED 32 0.0011
302 SPINAL DISORDER 10 0.0011
303 ECONOMIC PROBLEM 16 0.0011
304 IMPAIRED DRIVING ABILITY 12 0.0011
305 OSTEOPENIA 16 0.0011
306 POST-TRAUMATIC STRESS DISORDER 7 0.0010
307 THYROID DISORDER 16 0.0010
308 TRANSIENT ISCHAEMIC ATTACK 35 0.0010
309 RALES 6 0.0010
310 SKIN WARM 6 0.0010
311 DIZZINESS POSTURAL 10 0.0010
312 HYPOALBUMINAEMIA 8 0.0010
313 PRESYNCOPE 25 0.0010
314 CORONARY ARTERY OCCLUSION 14 0.0010
315 HEAD DISCOMFORT 18 0.0010
316 HOSPICE CARE 10 0.0010
317 ROTATOR CUFF SYNDROME 13 0.0010
318 SKIN LACERATION 11 0.0010
319 SINUS HEADACHE 6 0.0010
320 BLOOD ALBUMIN DECREASED 8 0.0010
321 FACIAL PAIN 9 0.0010
322 RHINORRHOEA 65 0.0010
323 HIATUS HERNIA 13 0.0010
324 OSTEOPOROSIS 41 0.0010
325 CORONARY ARTERY DISEASE 30 0.0010
326 FRUSTRATION TOLERANCE DECREASED 8 0.0010
327 SEASONAL ALLERGY 14 0.0010
328 BONE DISORDER 18 0.0010
329 MENISCUS INJURY 6 0.0010
330 DYSPHONIA 57 0.0010
331 HEART RATE IRREGULAR 22 0.0010
332 SPINAL COMPRESSION FRACTURE 8 0.0010
333 HYPERTHYROIDISM 14 0.0010
334 ATRIAL FIBRILLATION 94 0.0010
335 TOOTH EXTRACTION 12 0.0010
336 PRE-EXISTING CONDITION IMPROVED 6 0.0010
337 PETECHIAE 10 0.0010
338 DEAFNESS 25 0.0010
339 HALLUCINATION 72 0.0010
340 DRUG TOXICITY 13 0.0010
341 GINGIVAL BLEEDING 13 0.0010
342 SUPRAVENTRICULAR TACHYCARDIA 9 0.0009
343 PRODUCT SUBSTITUTION ISSUE 54 0.0009
344 HYPOKALAEMIA 43 0.0009
345 DEMENTIA 26 0.0009
346 CARDIAC FLUTTER 6 0.0009
347 PAROSMIA 7 0.0009
348 BALANCE DISORDER 80 0.0009
349 DYSURIA 34 0.0009
350 HYPONATRAEMIA 52 0.0009
351 AGEUSIA 23 0.0009
352 PLATELET COUNT INCREASED 12 0.0009
353 SYNCOPE 92 0.0009
354 HEAD INJURY 29 0.0009
355 DIALYSIS 13 0.0009
356 ACIDOSIS 7 0.0009
357 SKIN DISCOLOURATION 42 0.0009
358 ASPIRATION 10 0.0009
359 URINARY INCONTINENCE 27 0.0009
360 TOOTH INFECTION 12 0.0009
361 WALKING AID USER 6 0.0009
362 SUBDURAL HAEMATOMA 13 0.0009
363 PARALYSIS 13 0.0009
364 BURSITIS 11 0.0009
365 INABILITY TO AFFORD MEDICATION 9 0.0009
366 LOW DENSITY LIPOPROTEIN INCREASED 7 0.0009
367 HOT FLUSH 68 0.0009
368 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 7 0.0009
369 CONSTIPATION 195 0.0009
370 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
371 URINARY TRACT INFECTION 152 0.0009
372 POLLAKIURIA 37 0.0009
373 ACUTE MYOCARDIAL INFARCTION 26 0.0009
374 PULMONARY MASS 13 0.0009
375 HYPERSOMNIA 25 0.0009
376 NIGHT SWEATS 28 0.0009
377 LYMPHOEDEMA 6 0.0009
378 CONFUSIONAL STATE 140 0.0009
379 HYPOGLYCAEMIA 42 0.0009
380 BACK DISORDER 14 0.0009
381 SHOCK HAEMORRHAGIC 7 0.0009
382 SINUS DISORDER 17 0.0009
383 BLOOD PRESSURE DECREASED 57 0.0009
384 ERECTILE DYSFUNCTION 22 0.0009
385 FALL 285 0.0009
386 FEAR 23 0.0009
387 ESCHERICHIA INFECTION 7 0.0009
388 ABASIA 21 0.0008
389 EXPOSURE VIA SKIN CONTACT 22 0.0008
390 THROAT IRRITATION 38 0.0008
391 CARDIAC FAILURE CONGESTIVE 68 0.0008
392 HYPOTENSION 169 0.0008
393 GALLBLADDER DISORDER 15 0.0008
394 THERAPY INTERRUPTED 60 0.0008
395 MYOCLONUS 10 0.0008
396 NIGHTMARE 29 0.0008
397 LACTIC ACIDOSIS 27 0.0008
398 HAEMODIALYSIS 7 0.0008
399 GASTROOESOPHAGEAL REFLUX DISEASE 67 0.0008
400 RASH PRURITIC 45 0.0008
401 DYSSTASIA 24 0.0008
402 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
403 HAEMORRHOIDS 16 0.0008
404 ACCIDENTAL OVERDOSE 30 0.0008
405 MOUTH HAEMORRHAGE 6 0.0008
406 LETHARGY 47 0.0008
407 SKIN HYPERPIGMENTATION 7 0.0008
408 METABOLIC ACIDOSIS 26 0.0008
409 CARDIAC MURMUR 7 0.0008
410 GENERALISED OEDEMA 10 0.0008
411 IMPAIRED GASTRIC EMPTYING 11 0.0008
412 CYST 10 0.0008
413 MALNUTRITION 9 0.0008
414 SNEEZING 18 0.0008
415 PRESCRIBED UNDERDOSE 16 0.0008
416 HYDRONEPHROSIS 6 0.0008
417 BLOOD CALCIUM INCREASED 7 0.0008
418 GROIN PAIN 7 0.0008
419 BLEPHAROSPASM 5 0.0008
420 SLEEP DISORDER 56 0.0008
421 HYPERTENSION 168 0.0008
422 MENTAL STATUS CHANGES 22 0.0008
423 BLOOD COUNT ABNORMAL 12 0.0008
424 PURPURA 7 0.0008
425 POOR QUALITY SLEEP 17 0.0008
426 MUSCLE ATROPHY 10 0.0008
427 DERMATITIS CONTACT 9 0.0008
428 TROPONIN INCREASED 6 0.0008
429 ARTHRITIS 62 0.0008
430 OEDEMA PERIPHERAL 96 0.0008
431 WRONG DRUG ADMINISTERED 7 0.0008
432 DRUG DISPENSING ERROR 12 0.0008
433 BOWEL MOVEMENT IRREGULARITY 6 0.0008
434 MATERNAL DRUGS AFFECTING FOETUS 6 0.0008
435 EXPIRED PRODUCT ADMINISTERED 26 0.0008
436 LEUKOCYTOSIS 14 0.0008
437 HYPERBILIRUBINAEMIA 8 0.0008
438 BLOOD CHOLESTEROL INCREASED 36 0.0008
439 DIZZINESS 385 0.0008
440 OPTIC NEURITIS 7 0.0008
441 DYSPNOEA EXERTIONAL 29 0.0008
442 HAEMORRHAGIC STROKE 6 0.0008
443 CARDIOGENIC SHOCK 11 0.0008
444 EXOSTOSIS 7 0.0008
445 BLOOD POTASSIUM DECREASED 23 0.0008
446 WEIGHT FLUCTUATION 8 0.0008
447 GAIT DISTURBANCE 146 0.0008
448 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
449 GASTRITIS 20 0.0008
450 ORAL CANDIDIASIS 10 0.0008
451 PULMONARY OEDEMA 34 0.0008
452 ACTIVITIES OF DAILY LIVING IMPAIRED 15 0.0008
453 JOINT DISLOCATION 8 0.0008
454 SOPOR 10 0.0008
455 BLOOD PRESSURE INCREASED 115 0.0008
456 BLOOD PRESSURE FLUCTUATION 18 0.0007
457 SENSORY DISTURBANCE 12 0.0007
458 ASTHENIA 280 0.0007
459 LEUKAEMIA 7 0.0007
460 BURNING SENSATION 52 0.0007
461 BLOOD POTASSIUM INCREASED 12 0.0007
462 COLD SWEAT 13 0.0007
463 BLOOD URINE PRESENT 14 0.0007
464 DECUBITUS ULCER 6 0.0007
465 DIABETES MELLITUS 56 0.0007
466 ANAEMIA 140 0.0007
467 PULMONARY THROMBOSIS 8 0.0007
468 INTERVERTEBRAL DISC PROTRUSION 16 0.0007
469 DECREASED APPETITE 170 0.0007
470 GASTROINTESTINAL HAEMORRHAGE 61 0.0007
471 VENTRICULAR TACHYCARDIA 12 0.0007
472 DENTAL CARIES 8 0.0007
473 EMBOLISM 6 0.0007
474 FOOT DEFORMITY 8 0.0007
475 FUNGAL INFECTION 24 0.0007
476 ARRHYTHMIA 34 0.0007
477 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
478 CONTUSION 69 0.0007
479 DYSPHAGIA 68 0.0007
480 UPPER GASTROINTESTINAL HAEMORRHAGE 12 0.0007
481 KNEE OPERATION 7 0.0007
482 TENDONITIS 11 0.0007
483 LYMPHOPENIA 10 0.0007
484 SWELLING FACE 46 0.0007
485 WEIGHT DECREASED 197 0.0007
486 EATING DISORDER 15 0.0007
487 BLOOD PRESSURE ABNORMAL 14 0.0007
488 INTERNATIONAL NORMALISED RATIO INCREASED 20 0.0007
489 HEPATIC STEATOSIS 13 0.0007
490 CHRONIC KIDNEY DISEASE 53 0.0007
491 STAPHYLOCOCCAL INFECTION 23 0.0007
492 GASTRIC HAEMORRHAGE 8 0.0007
493 BLOOD MAGNESIUM DECREASED 6 0.0007
494 MUSCULAR WEAKNESS 79 0.0007
495 TOXIC SKIN ERUPTION 7 0.0007
496 PERICARDIAL EFFUSION 16 0.0007
497 AMNESIA 45 0.0007
498 SKIN SWELLING 6 0.0007
499 ANOSMIA 10 0.0007
500 MOTOR DYSFUNCTION 7 0.0007
501 SLUGGISHNESS 7 0.0007
502 DEVICE USE ISSUE 12 0.0007
503 NAIL DISORDER 6 0.0007
504 PRODUCT QUALITY ISSUE 93 0.0007
505 FATIGUE 532 0.0007
506 SLEEP APNOEA SYNDROME 13 0.0007
507 HAEMOPTYSIS 19 0.0007
508 SOMNOLENCE 137 0.0007
509 LUNG INFILTRATION 6 0.0007
510 LOSS OF CONSCIOUSNESS 87 0.0007
511 BRONCHITIS 50 0.0007
512 BLOOD IRON DECREASED 8 0.0007
513 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
514 FLUID RETENTION 34 0.0007
515 EPISTAXIS 50 0.0007
516 TRANSFUSION 7 0.0007
517 INTENTIONAL DOSE OMISSION 19 0.0007
518 SCRATCH 7 0.0007
519 INCONTINENCE 7 0.0007
520 SUDDEN DEATH 7 0.0007
521 UNRESPONSIVE TO STIMULI 17 0.0007
522 HYPERGLYCAEMIA 24 0.0007
523 TOXIC EPIDERMAL NECROLYSIS 10 0.0007
524 PALPITATIONS 77 0.0007
525 HAEMATOMA 17 0.0007
526 DISCOMFORT 40 0.0007
527 INSURANCE ISSUE 10 0.0007
528 INCREASED TENDENCY TO BRUISE 6 0.0007
529 SKIN EXFOLIATION 55 0.0007
530 SPINAL FRACTURE 13 0.0006
531 CHEST PAIN 120 0.0006
532 MEDICATION ERROR 36 0.0006
533 ORAL DISCOMFORT 9 0.0006
534 MUSCULOSKELETAL CHEST PAIN 10 0.0006
535 FAECES DISCOLOURED 14 0.0006
536 PHARYNGITIS 8 0.0006
537 PANCYTOPENIA 36 0.0006
538 BACTERIAL INFECTION 12 0.0006
539 NERVOUS SYSTEM DISORDER 20 0.0006
540 RENAL FAILURE 85 0.0006
541 MUSCULOSKELETAL DISCOMFORT 11 0.0006
542 BRAIN FOG 10 0.0006
543 CONDITION AGGRAVATED 193 0.0006
544 SINUS TACHYCARDIA 9 0.0006
545 HAEMOGLOBIN DECREASED 65 0.0006
546 MUSCULOSKELETAL DISORDER 12 0.0006
547 HYPERTENSIVE CRISIS 7 0.0006
548 UPPER RESPIRATORY TRACT INFECTION 29 0.0006
549 IMPAIRED QUALITY OF LIFE 9 0.0006
550 CHEST DISCOMFORT 64 0.0006
551 BLOOD GLUCOSE DECREASED 30 0.0006
552 PLEURAL EFFUSION 38 0.0006
553 DRUG INTERACTION 99 0.0006
554 ACUTE RESPIRATORY FAILURE 12 0.0006
555 BLOOD CALCIUM DECREASED 7 0.0006
556 HIP FRACTURE 20 0.0006
557 DYSGEUSIA 46 0.0006
558 COUGH 173 0.0006
559 PERIPHERAL SWELLING 95 0.0006
560 VITAMIN D DEFICIENCY 6 0.0006
561 HYPOAESTHESIA 92 0.0006
562 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 32 0.0006
563 ABDOMINAL DISTENSION 64 0.0006
564 NODULE 8 0.0006
565 NASAL CONGESTION 36 0.0006
566 PRODUCT DOSE OMISSION ISSUE 180 0.0006
567 ARTHROPATHY 34 0.0006
568 ABNORMAL FAECES 5 0.0006
569 NEUROPATHY PERIPHERAL 58 0.0006
570 BODY TEMPERATURE DECREASED 6 0.0006
571 GASTROENTERITIS VIRAL 11 0.0006
572 HERPES ZOSTER 35 0.0006
573 JOINT INJURY 13 0.0006
574 ERYTHEMA 125 0.0006
575 BACK PAIN 141 0.0006
576 LIGAMENT SPRAIN 6 0.0006
577 SINUSITIS 62 0.0006
578 RESTLESS LEGS SYNDROME 11 0.0006
579 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
580 FEELING HOT 37 0.0006
581 TREATMENT NONCOMPLIANCE 33 0.0006
582 END STAGE RENAL DISEASE 11 0.0006
583 ABDOMINAL DISCOMFORT 101 0.0006
584 RASH MACULAR 21 0.0006
585 COAGULOPATHY 10 0.0006
586 BRAIN INJURY 6 0.0006
587 HAIR TEXTURE ABNORMAL 8 0.0006
588 HYPOTHYROIDISM 19 0.0006
589 HYPOTHERMIA 6 0.0006
590 FREQUENT BOWEL MOVEMENTS 16 0.0006
591 TASTE DISORDER 12 0.0006
592 PLATELET COUNT DECREASED 63 0.0006
593 NECK PAIN 33 0.0006
594 BACTERAEMIA 7 0.0006
595 MIDDLE INSOMNIA 11 0.0006
596 BODY TEMPERATURE INCREASED 12 0.0006
597 PRODUCT PRESCRIBING ERROR 14 0.0006
598 ACCIDENT 7 0.0006
599 NEUTROPHIL COUNT INCREASED 6 0.0006
600 DYSPNOEA 331 0.0006
601 TOOTH DISORDER 13 0.0006
602 RIB FRACTURE 12 0.0006
603 FLATULENCE 33 0.0006
604 FEMUR FRACTURE 18 0.0006
605 JOINT SWELLING 70 0.0006
606 THERAPEUTIC RESPONSE UNEXPECTED 26 0.0006
607 DYSPEPSIA 57 0.0006
608 DEHYDRATION 77 0.0006
609 CARDIAC DISORDER 54 0.0006
610 LABORATORY TEST ABNORMAL 17 0.0006
611 NEURALGIA 14 0.0006
612 INSOMNIA 153 0.0006
613 WHITE BLOOD CELL COUNT INCREASED 22 0.0006
614 APHONIA 8 0.0006
615 MUSCLE SPASMS 105 0.0006
616 ANHEDONIA 15 0.0006
617 MOBILITY DECREASED 41 0.0006
618 ALOPECIA 112 0.0006
619 URINARY RETENTION 19 0.0006
620 SMALL INTESTINAL OBSTRUCTION 7 0.0006
621 ERUCTATION 11 0.0006
622 SPINAL OPERATION 7 0.0006
623 HYPOXIA 20 0.0006
624 BLOOD TRIGLYCERIDES INCREASED 10 0.0006
625 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
626 MUSCLE TWITCHING 13 0.0006
627 BLOOD ALKALINE PHOSPHATASE INCREASED 14 0.0006
628 BONE PAIN 33 0.0006
629 WHITE BLOOD CELL COUNT DECREASED 61 0.0006
630 WHEEZING 33 0.0006
631 DECREASED ACTIVITY 6 0.0006
632 DEPRESSED LEVEL OF CONSCIOUSNESS 22 0.0006
633 ANAL INCONTINENCE 5 0.0006
634 HEART RATE INCREASED 55 0.0006
635 NERVOUSNESS 29 0.0006
636 DIARRHOEA 357 0.0006
637 TOOTHACHE 10 0.0006
638 INJECTION SITE HAEMATOMA 8 0.0006
639 LIVER FUNCTION TEST ABNORMAL 16 0.0005
640 LIMB DISCOMFORT 17 0.0005
641 BLOOD GLUCOSE FLUCTUATION 6 0.0005
642 SWOLLEN TONGUE 17 0.0005
643 STOMATITIS 33 0.0005
644 RESPIRATORY DISTRESS 15 0.0005
645 INFUSION SITE PAIN 7 0.0005
646 FEEDING DISORDER 11 0.0005
647 DIVERTICULITIS 15 0.0005
648 BONE MARROW FAILURE 11 0.0005
649 ANXIETY 154 0.0005
650 LOCALISED INFECTION 13 0.0005
651 COLON CANCER 8 0.0005
652 IMMUNODEFICIENCY 8 0.0005
653 BLOOD CREATININE INCREASED 35 0.0005
654 ORAL PAIN 12 0.0005
655 COGNITIVE DISORDER 25 0.0005
656 ECZEMA 28 0.0005
657 HAEMORRHAGE INTRACRANIAL 8 0.0005
658 SKIN INFECTION 6 0.0005
659 OEDEMA 29 0.0005
660 THERAPY NON-RESPONDER 24 0.0005
661 FACE OEDEMA 9 0.0005
662 DRUG INEFFECTIVE 703 0.0005
663 PAIN IN EXTREMITY 157 0.0005
664 BEDRIDDEN 7 0.0005
665 PRURITUS 204 0.0005
666 DISORIENTATION 21 0.0005
667 UNEVALUABLE EVENT 40 0.0005
668 CIRCULATORY COLLAPSE 9 0.0005
669 ADVERSE REACTION 7 0.0005
670 DEPRESSION 120 0.0005
671 MYOCARDIAL INFARCTION 92 0.0005
672 HAEMATURIA 18 0.0005
673 MICTURITION URGENCY 6 0.0005
674 ANGINA PECTORIS 15 0.0005
675 INJECTION SITE REACTION 36 0.0005
676 HEADACHE 328 0.0005
677 ACUTE KIDNEY INJURY 80 0.0005
678 SHOCK 12 0.0005
679 LOWER LIMB FRACTURE 10 0.0005
680 METASTASES TO LUNG 6 0.0005
681 PNEUMONIA 168 0.0005
682 SINUS CONGESTION 7 0.0005
683 MUSCULOSKELETAL STIFFNESS 45 0.0005
684 CHOKING 10 0.0005
685 SEXUAL DYSFUNCTION 6 0.0005
686 SEPSIS 57 0.0005
687 VIRAL INFECTION 17 0.0005
688 GAIT INABILITY 17 0.0005
689 HYPOPHAGIA 13 0.0005
690 DEEP VEIN THROMBOSIS 33 0.0005
691 CEREBROVASCULAR ACCIDENT 86 0.0005
692 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 36 0.0005
693 PULMONARY EMBOLISM 48 0.0005
694 RENAL INJURY 15 0.0005
695 PNEUMOTHORAX 8 0.0005
696 COMA 24 0.0005
697 SWELLING 47 0.0005
698 OBESITY 8 0.0005
699 THROMBOCYTOPENIA 56 0.0005
700 RENAL IMPAIRMENT 42 0.0005
701 BLISTER 28 0.0005
702 OSTEOMYELITIS 9 0.0005
703 HYPERHIDROSIS 64 0.0005
704 SPEECH DISORDER 26 0.0005
705 RENAL DISORDER 23 0.0005
706 FIBROMYALGIA 12 0.0005
707 DYSKINESIA 20 0.0005
708 DEPRESSED MOOD 26 0.0005
709 BRONCHOSPASM 7 0.0005
710 BLOOD GLUCOSE INCREASED 92 0.0005
711 MYALGIA 83 0.0005
712 CHOLELITHIASIS 16 0.0005
713 HYPOACUSIS 21 0.0005
714 HYPERCALCAEMIA 6 0.0005
715 TACHYCARDIA 43 0.0005
716 JAUNDICE 13 0.0005
717 THINKING ABNORMAL 9 0.0005
718 TOOTH LOSS 10 0.0005
719 HYPOKINESIA 7 0.0005
720 HAIR COLOUR CHANGES 6 0.0005
721 RASH ERYTHEMATOUS 23 0.0005
722 PNEUMONIA ASPIRATION 12 0.0005
723 SKIN IRRITATION 22 0.0005
724 PULMONARY HYPERTENSION 10 0.0005
725 APATHY 7 0.0005
726 SKIN DISORDER 16 0.0005
727 DERMATITIS ALLERGIC 6 0.0005
728 MALAISE 209 0.0005
729 DRUG INTOLERANCE 46 0.0005
730 RHEUMATOID ARTHRITIS 54 0.0005
731 HYPOCALCAEMIA 9 0.0005
732 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
733 KNEE ARTHROPLASTY 10 0.0005
734 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 26 0.0005
735 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 16 0.0005
736 HAEMATEMESIS 12 0.0005
737 PANCREATITIS 25 0.0005
738 DRUG EFFECT LESS THAN EXPECTED 7 0.0005
739 HEMIPARESIS 8 0.0005
740 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 95 0.0005
741 PRODUCT STORAGE ERROR 41 0.0005
742 SCAR 8 0.0005
743 FEELING COLD 13 0.0005
744 ACCIDENTAL EXPOSURE TO PRODUCT 48 0.0005
745 RASH 203 0.0005
746 METASTASES TO CENTRAL NERVOUS SYSTEM 6 0.0005
747 SKIN CANCER 10 0.0005
748 MULTI-ORGAN FAILURE 8 0.0005
749 PRURITUS GENERALISED 10 0.0005
750 PLASMA CELL MYELOMA 18 0.0005
751 RESPIRATORY TRACT INFECTION 12 0.0005
752 DEVICE FAILURE 7 0.0005
753 PRODUCT DOSE OMISSION 30 0.0005
754 PAIN IN JAW 13 0.0005
755 PRODUCT USE ISSUE 86 0.0005
756 INCORRECT DOSE ADMINISTERED 104 0.0005
757 METASTASES TO LIVER 8 0.0005
758 MENTAL IMPAIRMENT 11 0.0005
759 NAUSEA 358 0.0005
760 ARTHRALGIA 188 0.0005
761 LYMPHADENOPATHY 16 0.0005
762 LIVER DISORDER 20 0.0005
763 ACUTE MYELOID LEUKAEMIA 7 0.0004
764 LUNG DISORDER 22 0.0004
765 THERAPY PARTIAL RESPONDER 7 0.0004
766 CARDIAC ARREST 37 0.0004
767 ENCEPHALOPATHY 11 0.0004
768 RASH PAPULAR 10 0.0004
769 PRODUCT PHYSICAL ISSUE 9 0.0004
770 GOUT 8 0.0004
771 INTENTIONAL PRODUCT MISUSE 39 0.0004
772 CYANOSIS 7 0.0004
773 OROPHARYNGEAL PAIN 41 0.0004
774 FEELING ABNORMAL 106 0.0004
775 DRY SKIN 59 0.0004
776 RESPIRATORY TRACT CONGESTION 7 0.0004
777 DRUG EFFECT INCOMPLETE 16 0.0004
778 VOMITING 207 0.0004
779 AKATHISIA 6 0.0004
780 CYSTITIS 14 0.0004
781 ABSCESS 7 0.0004
782 SKIN LESION 12 0.0004
783 NEPHROLITHIASIS 20 0.0004
784 CHILLS 51 0.0004
785 THROMBOSIS 35 0.0004
786 HAEMATOCHEZIA 24 0.0004
787 MUSCLE TIGHTNESS 7 0.0004
788 COORDINATION ABNORMAL 6 0.0004
789 MEMORY IMPAIRMENT 59 0.0004
790 NASOPHARYNGITIS 79 0.0004
791 PAIN 260 0.0004
792 ADVERSE EVENT 39 0.0004
793 INTENTIONAL PRODUCT USE ISSUE 37 0.0004
794 RETCHING 9 0.0004
795 FOOT FRACTURE 8 0.0004
796 ATAXIA 5 0.0004
797 GASTRIC ULCER 8 0.0004
798 LIP SWELLING 14 0.0004
799 MUSCULOSKELETAL PAIN 22 0.0004
800 WEIGHT INCREASED 94 0.0004
801 PARAESTHESIA 66 0.0004
802 RECTAL HAEMORRHAGE 18 0.0004
803 PRODUCTIVE COUGH 20 0.0004
804 CELLULITIS 21 0.0004
805 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 75 0.0004
806 PARAESTHESIA ORAL 6 0.0004
807 CLOSTRIDIUM DIFFICILE INFECTION 9 0.0004
808 FLUID OVERLOAD 6 0.0004
809 RESPIRATORY FAILURE 30 0.0004
810 OXYGEN SATURATION DECREASED 23 0.0004
811 MELAENA 9 0.0004
812 DRUG EFFECT DECREASED 22 0.0004
813 ASCITES 12 0.0004
814 ABDOMINAL PAIN UPPER 84 0.0004
815 BLOOD BILIRUBIN INCREASED 11 0.0004
816 ROAD TRAFFIC ACCIDENT 17 0.0004
817 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9 0.0004
818 LIMB INJURY 11 0.0004
819 TRANSAMINASES INCREASED 9 0.0004
820 DISABILITY 8 0.0004
821 PALLOR 11 0.0004
822 PRODUCT USE IN UNAPPROVED INDICATION 100 0.0004
823 CONVULSION 23 0.0004
824 LOCAL SWELLING 7 0.0004
825 RESPIRATORY DISORDER 12 0.0004
826 COVID-19 70 0.0004
827 ABNORMAL DREAMS 11 0.0004
828 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
829 HIP ARTHROPLASTY 6 0.0004
830 MALIGNANT NEOPLASM PROGRESSION 40 0.0004
831 DEVICE RELATED INFECTION 6 0.0004
832 EMOTIONAL DISORDER 12 0.0004
833 GENERAL PHYSICAL HEALTH DETERIORATION 45 0.0004
834 LYMPHOMA 6 0.0004
835 ANAPHYLACTIC SHOCK 10 0.0004
836 ANKLE FRACTURE 6 0.0004
837 SKIN ULCER 10 0.0004
838 CARDIO-RESPIRATORY ARREST 16 0.0004
839 LEUKOPENIA 19 0.0004
840 MIGRAINE 36 0.0004
841 MOOD SWINGS 12 0.0004
842 INJECTION SITE HAEMORRHAGE 30 0.0004
843 IMPAIRED WORK ABILITY 8 0.0004
844 HOSPITALISATION 57 0.0004
845 INJURY 26 0.0004
846 UNDERDOSE 27 0.0004
847 ILLNESS 38 0.0004
848 INFLAMMATION 19 0.0004
849 PRODUCT DISPENSING ERROR 8 0.0004
850 IRRITABILITY 22 0.0004
851 PULMONARY FIBROSIS 7 0.0004
852 INFLUENZA LIKE ILLNESS 30 0.0004
853 SEROTONIN SYNDROME 7 0.0004
854 DISEASE PROGRESSION 43 0.0004
855 THERAPEUTIC RESPONSE DECREASED 22 0.0004
856 PSYCHOMOTOR HYPERACTIVITY 6 0.0004
857 RHABDOMYOLYSIS 15 0.0004
858 RASH MACULO-PAPULAR 8 0.0004
859 HEPATOTOXICITY 8 0.0004
860 INFECTION 52 0.0004
861 DRUG ADMINISTRATION ERROR 11 0.0004
862 CRYING 13 0.0004
863 ABDOMINAL PAIN 83 0.0004
864 TREMOR 59 0.0004
865 RESTLESSNESS 13 0.0004
866 ABNORMAL BEHAVIOUR 14 0.0004
867 UPPER LIMB FRACTURE 7 0.0004
868 INTERSTITIAL LUNG DISEASE 17 0.0004
869 INFLUENZA 39 0.0003
870 GASTRIC DISORDER 12 0.0003
871 OFF LABEL USE 306 0.0003
872 RASH GENERALISED 9 0.0003
873 NEOPLASM PROGRESSION 12 0.0003
874 PSORIATIC ARTHROPATHY 14 0.0003
875 NEOPLASM MALIGNANT 23 0.0003
876 JOINT STIFFNESS 9 0.0003
877 AGITATION 25 0.0003
878 CARDIAC FAILURE 27 0.0003
879 ASTHMA 38 0.0003
880 CEREBRAL HAEMORRHAGE 12 0.0003
881 GASTROINTESTINAL DISORDER 30 0.0003
882 PAIN OF SKIN 9 0.0003
883 THROAT TIGHTNESS 9 0.0003
884 DRUG DOSE OMISSION 55 0.0003
885 MOUTH ULCERATION 7 0.0003
886 DEATH 286 0.0003
887 THERAPEUTIC RESPONSE SHORTENED 11 0.0003
888 PNEUMONITIS 9 0.0003
889 MOOD ALTERED 9 0.0003
890 URTICARIA 55 0.0003
891 CEREBRAL INFARCTION 8 0.0003
892 SURGERY 19 0.0003
893 HEPATIC ENZYME INCREASED 22 0.0003
894 DERMATITIS ATOPIC 17 0.0003
895 SEPTIC SHOCK 14 0.0003
896 MENTAL DISORDER 14 0.0003
897 PYREXIA 110 0.0003
898 FRACTURE 6 0.0003
899 DELIRIUM 11 0.0003
900 PRODUCT COMPLAINT 8 0.0003
901 HAEMORRHAGE 33 0.0003
902 CARDIOVASCULAR DISORDER 8 0.0003
903 FLUSHING 32 0.0003
904 INCREASED APPETITE 6 0.0003
905 GLOSSODYNIA 7 0.0003
906 CHOLESTASIS 6 0.0003
907 MOVEMENT DISORDER 10 0.0003
908 HERNIA 6 0.0003
909 NEUTROPENIA 42 0.0003
910 IMPAIRED HEALING 10 0.0003
911 AGGRESSION 15 0.0003
912 TYPE 2 DIABETES MELLITUS 10 0.0003
913 ANGER 10 0.0003
914 NEUTROPHIL COUNT DECREASED 12 0.0003
915 DISEASE RECURRENCE 14 0.0003
916 DYSARTHRIA 11 0.0003
917 INTESTINAL OBSTRUCTION 11 0.0003
918 INJECTION SITE WARMTH 6 0.0003
919 GYNAECOMASTIA 9 0.0003
920 ADVERSE DRUG REACTION 26 0.0003
921 EMOTIONAL DISTRESS 35 0.0003
922 FEBRILE NEUTROPENIA 19 0.0003
923 OSTEONECROSIS OF JAW 7 0.0003
924 EXTRAPYRAMIDAL DISORDER 7 0.0003
925 IRRITABLE BOWEL SYNDROME 6 0.0003
926 ELECTROCARDIOGRAM QT PROLONGED 10 0.0003
927 ALANINE AMINOTRANSFERASE INCREASED 17 0.0003
928 ABDOMINAL PAIN LOWER 7 0.0003
929 EXTRA DOSE ADMINISTERED 11 0.0003
930 AGRANULOCYTOSIS 5 0.0003
931 SEDATION 7 0.0003
932 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 19 0.0003
933 CHROMATURIA 6 0.0003
934 DISTURBANCE IN ATTENTION 14 0.0003
935 RESPIRATORY ARREST 7 0.0003
936 SEIZURE 29 0.0003
937 ANGIOEDEMA 11 0.0002
938 WRONG TECHNIQUE IN DRUG USAGE PROCESS 9 0.0002
939 PANIC ATTACK 9 0.0002
940 THERAPEUTIC PRODUCT EFFECT DECREASED 11 0.0002
941 NO ADVERSE EVENT 44 0.0002
942 LOWER RESPIRATORY TRACT INFECTION 11 0.0002
943 INJECTION SITE BRUISING 19 0.0002
944 WITHDRAWAL SYNDROME 10 0.0002
945 COLITIS 9 0.0002
946 PSORIASIS 31 0.0002
947 ANAPHYLACTIC REACTION 13 0.0002
948 APHASIA 7 0.0002
949 MUCOSAL INFLAMMATION 6 0.0002
950 APPLICATION SITE ERYTHEMA 6 0.0002
951 INJECTION SITE RASH 7 0.0002
952 APPLICATION SITE PAIN 5 0.0002
953 INFUSION RELATED REACTION 15 0.0002
954 EAR INFECTION 6 0.0002
955 BONE DENSITY DECREASED 7 0.0002
956 SKIN BURNING SENSATION 16 0.0002
957 MULTIPLE SCLEROSIS RELAPSE 15 0.0002
958 PROCEDURAL PAIN 6 0.0002
959 WOUND 6 0.0002
960 DEVICE MALFUNCTION 15 0.0002
961 OSTEONECROSIS 7 0.0002
962 DEVICE ISSUE 19 0.0002
963 ACNE 16 0.0002
964 MULTIPLE SCLEROSIS 10 0.0002
965 DEVICE LEAKAGE 9 0.0002
966 SUICIDAL IDEATION 19 0.0002
967 DEVICE DISLOCATION 9 0.0002
968 BREAST CANCER 19 0.0002
969 HEPATIC FAILURE 6 0.0002
970 PROSTATE CANCER 16 0.0002
971 SYSTEMIC LUPUS ERYTHEMATOSUS 7 0.0002
972 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
973 INJECTION SITE MASS 7 0.0002
974 INJECTION SITE PAIN 58 0.0002
975 ILL-DEFINED DISORDER 11 0.0002
976 COLITIS ULCERATIVE 8 0.0002
977 THERAPY CESSATION 9 0.0002
978 BLOOD CREATINE PHOSPHOKINASE INCREASED 5 0.0002
979 LUNG NEOPLASM MALIGNANT 7 0.0002
980 INJECTION SITE ERYTHEMA 21 0.0002
981 C-REACTIVE PROTEIN INCREASED 6 0.0002
982 HEPATIC FUNCTION ABNORMAL 6 0.0002
983 INJECTION SITE PRURITUS 10 0.0001
984 INJECTION SITE SWELLING 11 0.0001
985 OVERDOSE 30 0.0001
986 DEVICE DIFFICULT TO USE 8 0.0001
987 SUICIDE ATTEMPT 7 0.0001
988 DRUG WITHDRAWAL SYNDROME 10 0.0001
989 TOXICITY TO VARIOUS AGENTS 17 0.0001
990 COMPLETED SUICIDE 6 0.0001
991 DRUG DEPENDENCE 11 0.0001